PÅL RYFORS – CEOPål Ryfors
@palryfors

Pål has a Bachelor in Financial Economics from Gothenburg School of Economics. He has vast experience from leading positions within the finance and banking sector both in the Nordics and internationally.

Most recently, he was the CFO of Marginalen Bank, a Swedish bank employing some 350 people, where Ryfors was responsible for the strategic financial planning and management, as well as leading the financial operations and implementing corporate development initiatives. Previously, Ryfors was Head of Group Controlling at Hoist Finance. Prior to joining Hoist Finance, Ryfors was an investment banker at Societe Generale, where he joined after holding several leading positions in the restructuring of the Swedish operations of Kaupthing Bank.

Other appointments: Board member Aros Kapital AB and Doxa AB

No of B shares: 1,016,393

No of employee stock options: 71,450

No of warrants: 15,000

No of warrants TO4B: 24,681

 

 

 

 

 

Veronica Wallin

VERONICA WALLIN – CFO

Veronica has a Degree of Master of Science in Business and Economics from Stockholms University and was employed by Episurf Medical in August 2016 as Head of Finance. In June 2017 Veronica became CFO after Pål Ryfors, who then resigned as CFO.

Prior to joining Episurf Medical Veronica worked as Head of Finance at ApoEx during 2013-2016.

No of B shares: 4,000

No of employee stock options: 44,350

No of warrants: 24,600

No of warrants TO4B: 148

 

 

 

 

 

 

 

 

 

Jeanette SpångbergJEANETTE SPÅNGBERG – COO

Jeanette has a Bachelor of Science in Construction Engineering, Information Technology and Environment. From 1999 to 2008, Jeanette worked as Production Manager at Nobel Biocare Procera AB, before being promoted to Technical Manager in 2008. At Nobel Biocare, Jeanette was, among other things, involved in building a quality system for ISO 9001 certification.

No of B shares: 9,422

No of employee stock options: 71,350

No of warrants: 8,000

No of warrants TO4B: 333

 

 

 

 

 

 

 

 

KATARINA FLODSTRÖM – CHIEF REGULATORY OFFICER                               – REGULATORY AFFAIRS, QUALITY AFFAIRS AND INTELLECTUAL PROPERTY

Katarina has a PhD in Physical Chemistry from Lund University and a MSc in Chemical Engineering from the Royal Institute of Technology in Stockholm. She was employed by Episurf Medical in 2014. Katarina has 15 years’ experience from RnD in start-up companies. She was the RnD Manager and Quality Manager of Diamorph AB from which Episurf is a spinn-off.

No of B shares: 25,000 (of which 7,000 is family members)

No of employee stock options: 42,400

No of warrants: 11,200

No of warrants TO4B: 555 (of which 259 is family members)

 

 

 

 

 

 

 

Göran Martinsson

GÖRAN MARTINSSON – SALES DIRECTOR

Göran was employed by Episurf Medical in August 2014. He has more than 30 years of experience from senior management roles in various technology companies on a global basis, including companies in the medical technology sector. Prior to joining Episurf Medical Göran worked at companies such as ArthroCare and Merivaara.

No of B shares: 47,680 (of which 7,340 is family members)

No of employee stock options: 53,550

No of warrants: 21,500

No of warrants TO4B: 913 (of which 271 is family members)

 

 

 

 

 

 

 

 

Fredrik ZetterbergFREDRIK ZETTERBERG – MARKETING DIRECTOR

Fredrik was employed by Episurf Medical AB in February 2016 and has 20 years of experience from medical technology companies such as Baxter, Cardinal Health, ArthroCare and Smith & Nephew.

Since 2008 the focus has been on orthopedics where he has held senior positions within sales management and international marketing.

No of B shares: 4,000

No of employee stock options: 35,450

No of warrants: 12,700

No of warrants TO4B: 148